Law360, New York (February 16, 2010, 1:35 PM ET) -- Israel-based Teva Pharmaceutical Industries Ltd.'s U.S. unit has settled a patent infringement suit brought by Novartis AG over a generic version of genital herpes drug Famvir.
Teva Pharmaceuticals USA Inc. will make a one-time payment to Novartis and pay ongoing royalties on future U.S. sales of the generic in exchange for a release from liability, Teva said.
No other terms were released, and a representative for Novartis could not immediately be reached for comment Tuesday. Settlement documents have not been filed in the case, which is...
Teva, Novartis Settle Suit Over Generic Famvir
To view the full article, take a free trial now.
